Amcor (AMCR) Q2 2026 earnings review
Synergies Mask Volume Weakness
Amcor's first full quarter post-Berry integration shows a company executing well on costs but struggling for organic growth. While reported sales surged 68% and Adjusted EPS rose 7% to $0.86 due to the acquisition, the underlying business is shrinking: volumes fell 1.5% on a comparable basis. The 1-for-5 reverse stock split cleans up the share structure, but the real story is the race between synergy extraction ($55M realized) and interest expense (doubled to $154M). Management reaffirmed FY26 guidance, betting on a back-half acceleration that requires macro stabilization.
🐂 Bull Case
Amcor realized $55M in synergies in Q2, hitting the upper end of expectations. With $93M realized in H1, the company is on track to exceed its $260M FY26 target, proving the Berry integration is creating tangible margin value.
The addition of Berry's assets has fundamentally altered the margin profile of the Rigid Packaging segment. Adjusted EBIT margins jumped 280 basis points YoY to 10.1%, demonstrating improved earnings quality in this segment.
🐻 Bear Case
Despite the massive inorganic boost, organic fundamentals remain weak. Volumes declined 1.5% compared to combined legacy operations, with notable weakness in North America and Europe. The company cannot cut costs forever to offset negative volume.
The cost of the merger is visible below the operating line. GAAP interest expense more than doubled YoY to $154M. This creates a higher hurdle rate for earnings growth and pressures Free Cash Flow, which fell 19% YoY to $289M.
⚖️ Verdict: ⚪
Neutral. The execution on the merger integration is excellent, but the macro environment is fighting back. Until organic volumes turn positive, Amcor is a cost-cutting story rather than a growth story.
Key Themes
Volume Contraction Persists
Management cites a 'challenging volume environment,' which is analyst code for 'we can't move product.' Comparable volumes dropped 1.5%, driven by weakness in North America and Europe. Specifically, the Flexibles segment saw a 2% volume decline. While 'Pet Food' and 'Meat' grew, 'Liquids' and 'Unconverted Film' dragged results down. This is a continuation of the softness seen in Q1 (down ~2%).
Rigid Packaging Margin Expansion
The Rigid segment is the star beneficiary of the merger. Adjusted EBIT margin expanded significantly from 7.3% in the prior year to 10.1% in 26Q2. This isn't just volume leverage; it reflects the higher-value mix of Berry's container/closure assets compared to legacy Amcor beverage exposure.
Synergy Capture Velocity
Amcor delivered $55M in synergies this quarter. This is a crucial metric because it confirms the deal rationale. The company needs to hit ~$167M in synergies in H2 to meet the $260M annual target. The current run-rate suggests this is achievable, acting as a buffer against soft sales.
Capital Structure Strain
Net debt stands at $14.1 billion. The cost of servicing this debt is eating into the synergy gains. GAAP interest expense rose from $72M last year to $154M this quarter. While expected, this reduces the margin for error if integration hits a snag.
Reverse Stock Split Confusion
Effective Jan 14, 2026, Amcor executed a 1-for-5 reverse split. This optics change moves the stock price out of the 'penny stock' territory but adds complexity to year-over-year comparisons for retail investors. All analysis here uses post-split figures ($0.86 EPS vs ~$0.17 legacy equivalent).
Other KPIs
Decelerating. Down from $358M in the prior year, despite higher earnings. The drag comes from $69M in cash costs related to the Berry transaction/restructuring. The company maintains full-year guidance of $1.8-$1.9B, implying a massive cash generation requirement in H2.
Stable. Up 23% on Constant Currency due to acquisition, but organic performance is flat-to-down (Volumes -2%). This segment is the core of the business and needs to stabilize organic volumes to drive true growth.
Accelerating. Up from 14.0% in the prior year (25Q2). This 120bps improvement signals that despite volume headwinds, the pricing power and cost synergies are effectively shielding profitability.
Guidance
Stable/Reaffirmed. Represents 12-17% growth vs FY25 (post-split basis). With H1 EPS at $1.83, the company needs to generate ~$2.24 in H2. This implies an acceleration in profitability, banking heavily on synergy ramp-up and seasonal volume improvements.
Stable/Reaffirmed. With H1 showing a cash outflow of $53M (YTD), the company must generate nearly $2 billion in H2. This is a steep hill, heavily reliant on working capital timing and the absence of further one-off merger costs.
Key Questions
Organic Volume Floor
Comparable volumes have been negative for multiple quarters (-1.5% in Q2). At what point does 'portfolio optimization' end and organic growth begin? Is there a specific quarter in FY26 where you project positive organic volume?
H2 Cash Flow Ramp
To hit the $1.8B-$1.9B FCF target after a negative H1, you need a historic cash generation performance in H2. What specific working capital levers are being pulled, and does this risk inventory availability?
Pricing Power vs. Deflation
With raw material pass-through having no material impact on sales this quarter, are you seeing any deflationary pressure from customers demanding price-downs beyond the raw material index mechanisms?